INC Research Financials

INCR Stock  USD 1.35  0.01  0.75%   
Based on the key indicators obtained from INC Research's historical financial statements, INC Research Holdings is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December. At this time, INC Research's Current Deferred Revenue is relatively stable compared to the past year. As of 11/25/2024, Net Debt is likely to grow to about 99.3 M, while Cash is likely to drop slightly above 51.8 M. Key indicators impacting INC Research's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio2.081.8542
Moderately Up
Very volatile
The financial analysis of INC Research is a critical element in measuring its lifeblood. Investors should not minimize INC Research's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(58.86 Million)

  
Understanding current and past INC Research Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of INC Research's financial statements are interrelated, with each one affecting the others. For example, an increase in INC Research's assets may result in an increase in income on the income statement.

INC Research Stock Summary

INC Research competes with AYR Strategies, Verano Holdings, Vext Science, Collegium Pharmaceutical, and Phibro Animal. InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel. Intercure operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 350 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINIL0011063760
CUSIPM549GJ111
LocationIsrael
Business Address85 Medinat ha-Yehudim
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.intercure.co
Phone972 7 746 05012
CurrencyUSD - US Dollar

INC Research Key Financial Ratios

INC Research Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets282.2M326.3M686.3M958.0M786.6M825.9M
Other Current Liab3.9M13.4M53.5M54.3M54.6M57.3M
Net Debt(10.3M)(31.2M)(87.3M)22.6M94.5M99.3M
Retained Earnings(151.0M)(191.2M)(186.5M)(141.6M)(204.0M)(214.2M)
Accounts Payable4.9M18.6M64.5M126.1M78.4M82.4M
Cash27.3M37.9M196.2M232.6M101.1M51.8M
Net Receivables8.9M15.4M37.5M40.8M61.1M64.2M
Inventory5.8M22.2M67.9M126.5M105.5M110.7M
Other Current Assets1.1M6.9M58.7M113.8M150.9M158.4M
Total Liab26.0M34.2M227.1M436.5M329.6M346.0M
Total Current Assets42.2M76.7M336.2M507.5M418.8M439.7M
Short Term Debt13.8M1.7M75.6M132.4M92.8M97.5M
Common Stock403.4M452.3M623.6M632.0M643.2M351.2M
Net Tangible Assets19.7M88.0M84.4M190.0M218.5M229.4M
Net Invested Capital270.3M277.7M532.3M729.0M625.5M391.4M
Short Long Term Debt13.8M2.6M72.3M128.0M88.2M50.4M
Net Working Capital19.6M46.8M142.6M194.8M192.9M202.6M
Capital Stock403.4M452.3M623.6M632.0M643.2M534.7M

INC Research Key Income Statement Accounts

The reason investors look at the income statement is to determine what INC Research's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201920202021202220232024 (projected)
Interest Expense1.8M264K5.0M14.7M24.2M25.4M
Total Revenue8.9M65.0M219.7M388.7M355.6M373.3M
Operating Income(80.1M)(1.4M)28.2M52.8M(41.6M)(39.5M)
Ebit(80.1M)(37.8M)30.1M52.8M(37.1M)(35.2M)
Ebitda(21.2M)(34.5M)37.4M64.5M(23.9M)(22.7M)
Income Before Tax(3.7M)(38.3M)18.7M43.8M(61.3M)(58.2M)
Net Income(3.0M)(36.0M)7.3M44.8M(62.0M)(58.9M)
Income Tax Expense(673K)(2.3M)11.4M93K2.2M1.1M
Net Interest Income(1.8M)(507K)(4.9M)(13.8M)(19.7M)(18.7M)
Interest Income141K21K130K844K5.4M5.6M

INC Research Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash22.0M10.6M158.3M36.4M(131.5M)(124.9M)
Free Cash Flow(4.0M)(13.0M)11.0M31.5M(56.3M)(53.4M)
Depreciation23K3.3M7.4M11.7M13.2M13.8M
Other Non Cash Items(56.2M)(2.4M)(5.9M)(10.2M)35.4M37.2M
Capital Expenditures1K20.8M14.0M19.7M2.6M4.6M
Net Income(3.0M)(36.0M)7.3M43.7M(63.5M)(60.4M)
End Period Cash Flow25.4M37.9M196.2M232.6M101.1M106.2M
Investments2.3M(626K)(1.2M)(142.5M)4.8M5.0M
Net Borrowings8.7M(506K)(13.6M)65.8M75.7M79.5M
Change To Netincome10.4M(8.9M)45.9M14.6M16.8M14.6M

INC Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining INC Research's current stock value. Our valuation model uses many indicators to compare INC Research value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across INC Research competition to find correlations between indicators driving INC Research's intrinsic value. More Info.
INC Research Holdings is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, INC Research's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value INC Research by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

INC Research Holdings Systematic Risk

INC Research's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. INC Research volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on INC Research Holdings correlated with the market. If Beta is less than 0 INC Research generally moves in the opposite direction as compared to the market. If INC Research Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one INC Research Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of INC Research is generally in the same direction as the market. If Beta > 1 INC Research moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in INC Research Stock are looking for potential investment opportunities by analyzing not only static indicators but also various INC Research's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of INC Research growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0144

At this time, INC Research's Price Earnings To Growth Ratio is relatively stable compared to the past year.

INC Research November 25, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of INC Research help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of INC Research Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of INC Research Holdings based on widely used predictive technical indicators. In general, we focus on analyzing INC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build INC Research's daily price indicators and compare them against related drivers.

Additional Tools for INC Stock Analysis

When running INC Research's price analysis, check to measure INC Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INC Research is operating at the current time. Most of INC Research's value examination focuses on studying past and present price action to predict the probability of INC Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INC Research's price. Additionally, you may evaluate how the addition of INC Research to your portfolios can decrease your overall portfolio volatility.